I have known and worked with some of them for more than 30 years. , Volume 15, Issue 3. Angiotensin II type 1 receptor (AT1R) is a promising therapeutic target for cardiovascular diseases. Int. Roustem Gareyev David has several funds of hedge funds under management. Mol. Bertrand. Compared with orthosteric ligands. Bertrand is a